$CBRS

Patel Yagnesh sold $1.0M of CBRS

Patel Yagnesh (Chief Accounting Officer) sold 6,079 shares of Cerebras Systems Inc. (CBRS) at an average of $171.53 ($162.45–$189.36, $1.04M total) across 29 trades on 2026-06-25.

Original reporting
SEC EDGAR · Patel Yagnesh
Published Jun 29, 2026, 8:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 8:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size (~$1.04M) by the Chief Accounting Officer, with holdings after the transaction reported as 4,000 shares.

02

Market read

Traders may monitor for follow-on insider activity, but this disclosure alone does not provide new operating or financial guidance.

03

What to watch

No 10b5-1 plan is noted, but the article provides no context on prior grants, tax events, or whether future sales are planned; without that, signal strength is weak.

Relevance 6/10Novelty 5/10Timing: Form 4 filed 2026-06-29 (covers sales dated 2026-06-25).

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Cerebras Systems (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems insider (Chief Accounting Officer) sold ~$1.04M of CBRS shares via open-market transactions on 2026-06-25.

Expected impact

Likely limited near-term impact; any effect should fade unless followed by additional disclosures or company-specific news.

Evidence & confidence

The filing is a Form 4 open-market sale with no 10b5-1 plan and a remaining holding of 4,000 shares, but it does not include earnings, guidance, or operational changes.

Market effects

Minimal; insider selling at a single company typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification/tax/compensation liquidity rather than a bearish view, especially given multiple trades across a range of prices.

Key entities

  • Cerebras Systems Inc.

    Subject of the Form 4 insider transaction; ticker CBRS.

  • Patel Yagnesh

    Chief Accounting Officer who sold 6,079 shares across 29 trades on 2026-06-25.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.